Literature DB >> 33580217

How 'killer' T cells could boost COVID immunity in face of new variants.

Heidi Ledford.   

Abstract

Entities:  

Keywords:  Immunology; SARS-CoV-2; Vaccines; Virology

Year:  2021        PMID： 33580217     DOI： 10.1038/d41586-021-00367-7

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.

Authors:  Alison Tarke; John Sidney; Conner K Kidd; Jennifer M Dan; Sydney I Ramirez; Esther Dawen Yu; Jose Mateus; Ricardo da Silva Antunes; Erin Moore; Paul Rubiro; Nils Methot; Elizabeth Phillips; Simon Mallal; April Frazier; Stephen A Rawlings; Jason A Greenbaum; Bjoern Peters; Davey M Smith; Shane Crotty; Daniela Weiskopf; Alba Grifoni; Alessandro Sette
Journal:  Cell Rep Med       Date:  2021-01-26
  1 in total
  8 in total

1.  How will emerging SARS-CoV-2 variants impact herd immunity?

Authors:  Giuseppe Lippi; Brandon M Henry
Journal:  Ann Transl Med       Date:  2021-04

2.  SARS-CoV-2 infection incidence during the first and second COVID-19 waves in Italy.

Authors:  Marco Vinceti; Tommaso Filippini; Kenneth J Rothman; Silvia Di Federico; Nicola Orsini
Journal:  Environ Res       Date:  2021-04-01       Impact factor: 8.431

3.  Coronavirus Variants-Will New mRNA Vaccines Meet the Challenge?

Authors:  Jennifer Welsh
Journal:  Engineering (Beijing)       Date:  2021-04-18       Impact factor: 7.553

4.  Prediction of suitable T and B cell epitopes for eliciting immunogenic response against SARS-CoV-2 and its mutant.

Authors:  Vidhu Agarwal; Akhilesh Tiwari; Pritish Varadwaj
Journal:  Netw Model Anal Health Inform Bioinform       Date:  2021-11-26

5.  Unveiling the Potential Role of Nanozymes in Combating the COVID-19 Outbreak.

Authors:  Jafar Ali; Saira Naveed Elahi; Asghar Ali; Hassan Waseem; Rameesha Abid; Mohamed M Mohamed
Journal:  Nanomaterials (Basel)       Date:  2021-05-18       Impact factor: 5.076

6.  The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro.

Authors:  Jinglu Lyu; Lirong Bao; Xin Shen; Caixia Yan; Cheng Zhang; Wei Wei; Yutao Yang; Jia Li; Jiajia Dong; Liying Xiao; Xuedong Zhou; Yan Li
Journal:  Int Immunopharmacol       Date:  2021-05-19       Impact factor: 5.714

7.  Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.

Authors:  Shira Weingarten-Gabbay; Susan Klaeger; Siranush Sarkizova; Leah R Pearlman; Da-Yuan Chen; Kathleen M E Gallagher; Matthew R Bauer; Hannah B Taylor; W Augustine Dunn; Christina Tarr; John Sidney; Suzanna Rachimi; Hasahn L Conway; Katelin Katsis; Yuntong Wang; Del Leistritz-Edwards; Melissa R Durkin; Christopher H Tomkins-Tinch; Yaara Finkel; Aharon Nachshon; Matteo Gentili; Keith D Rivera; Isabel P Carulli; Vipheaviny A Chea; Abishek Chandrashekar; Cansu Cimen Bozkus; Mary Carrington; Nina Bhardwaj; Dan H Barouch; Alessandro Sette; Marcela V Maus; Charles M Rice; Karl R Clauser; Derin B Keskin; Daniel C Pregibon; Nir Hacohen; Steven A Carr; Jennifer G Abelin; Mohsan Saeed; Pardis C Sabeti
Journal:  Cell       Date:  2021-06-03       Impact factor: 66.850

8.  Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models.

Authors:  Haiqiang Yang; Jessica Cao; Xiaoyang Lin; Jingwen Yue; Tarek Zieneldien; Janice Kim; Lianchun Wang; Jianmin Fang; Ruo-Pan Huang; Yun Bai; Kevin Sneed; Chuanhai Cao
Journal:  Viruses       Date:  2022-02-22       Impact factor: 5.048
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.